Monte Rosa Therapeutics, Inc. (GLUE)
14.38
-0.18
(-1.24%)
USD |
NASDAQ |
Aug 26, 16:00
14.39
+0.01
(+0.07%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Return Level : 14.38 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 14.38 |
| August 25, 2026 | 14.56 |
| August 24, 2026 | 13.78 |
| August 21, 2026 | 14.30 |
| August 20, 2026 | 14.78 |
| August 19, 2026 | 15.77 |
| August 18, 2026 | 15.03 |
| August 17, 2026 | 15.38 |
| August 14, 2026 | 15.50 |
| August 13, 2026 | 15.84 |
| August 12, 2026 | 15.95 |
| August 11, 2026 | 15.76 |
| August 10, 2026 | 15.82 |
| August 07, 2026 | 15.88 |
| August 06, 2026 | 15.71 |
| August 05, 2026 | 15.61 |
| August 04, 2026 | 16.08 |
| August 03, 2026 | 15.38 |
| July 31, 2026 | 16.52 |
| July 30, 2026 | 22.68 |
| July 29, 2026 | 21.56 |
| July 28, 2026 | 22.04 |
| July 27, 2026 | 22.56 |
| July 24, 2026 | 22.78 |
| July 23, 2026 | 23.03 |
| Date | Value |
|---|---|
| July 22, 2026 | 23.79 |
| July 21, 2026 | 23.63 |
| July 20, 2026 | 23.48 |
| July 17, 2026 | 24.56 |
| July 16, 2026 | 23.16 |
| July 15, 2026 | 23.41 |
| July 14, 2026 | 23.46 |
| July 13, 2026 | 21.98 |
| July 10, 2026 | 23.04 |
| July 09, 2026 | 24.52 |
| July 08, 2026 | 24.06 |
| July 07, 2026 | 24.40 |
| July 06, 2026 | 23.25 |
| July 02, 2026 | 24.21 |
| July 01, 2026 | 24.02 |
| June 30, 2026 | 24.20 |
| June 29, 2026 | 23.90 |
| June 26, 2026 | 22.29 |
| June 25, 2026 | 21.66 |
| June 24, 2026 | 20.85 |
| June 23, 2026 | 20.71 |
| June 22, 2026 | 18.67 |
| June 18, 2026 | 18.31 |
| June 17, 2026 | 18.41 |
| June 16, 2026 | 17.76 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Nurix Therapeutics, Inc. | 26.71 |
| Gilead Sciences, Inc. | 215.83 |
| Ironwood Pharmaceuticals, Inc. | 4.29 |
| Capricor Therapeutics, Inc. | 9.36 |
| Cue Biopharma, Inc. | 28.85 |